Hospira expresses confidence in future growth

Hospira has stated its confidence that it will be able to maintain its progress towards its growth targets in the coming months.

Speaking at the pharmaceutical company’s 2010 Annual Meeting of Shareholders, Hospira chairman and chief executive officer Christopher Begley has described 2009 as a “great year” for the firm.

The executive highlighted the company’s success in advancing the performance of its key businesses as well as its profitability during the last year.

He also pointed to Hospira’s Project Fuel optimisation initiative as an example of the company’s efforts to deliver maximum value for its shareholders and achieve “top-ranking financial performance”.

“In 2010, we continue to execute our strategy and advance innovative solutions to help our customers and patients address their pressing needs,” added Mr Begley.

This comes after the company published its first quarter financial results last month, highlighting year-on-year increases in both its net sales and its profit levels.